The US Food and Drug Administration's "Process Validation: General Principles and Practices" is now over three years old. Thus, it is shocking how many pharmaceutical and medical device manufacturers have not implemented the approach suggested in this guidance. In this presentation, Paul Pluta, Ph.D., analyzed and clarified the FDA process validation recommendations.
